ACTINIUM PHARMACEUTICALS, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $5.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-07
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $5.00K.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $7.00K.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $10.00K.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $12.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | Finance Lease, Right-of-Use Asset, after Accumulated Amortization as first filed |
|---|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $10.00K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $12.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $15.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $17.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $20.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $22.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $25.00K 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $27.00K 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $30.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $4.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $18.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $38.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $58.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $79.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $99.00K 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $119.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $140.00K 10-K · filed 2022-03-25 | |
| 2020-09-30 | $160.00K 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $181.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $201.00K 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $221.00K 10-K · filed 2021-03-31 | $221.07K 10-K · filed 2020-05-08 |
| 2019-09-30 | $241.40K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $261.72K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $282.05K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |